Journal of Antimicrobial Chemotherapy

Article	Citations
The case for ‘conservative pharmacotherapy’—authors’ response	114
Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection	92
Monitoring molecular markers associated with antimalarial drug resistance in south-east Senegal from 2021 to 2023	89
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review	75
Synergistic effects of colistin–rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay	71
Navigating the complexities of azole antifungal therapy through pharmacokinetic concepts: a case of prolonged isavuconazole toxicity	66
Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence	62
NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)	55
Drug–drug interaction between letermovir and ciclosporin in allogeneic haematopoietic cell transplantation recipients	52
Comparative in vitro efficacy of AR-12 derivatives against Streptococcus pyogenes	52
Impact of a kidney-sparing protocol for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections (CLOXECO): a quasi-experimental study	50
Relationship between posaconazole concentrations and clinical outcomes in paediatric cancer and haematopoietic stem cell transplant recipients	50
Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized	47
BSAC Vanguard Series: Clean water—the world’s best medicine for disease and drug-resistant infection	46
Evaluation of a diagnostic algorithm for rapid identification of Gram-negative species and detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures	45
Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR	44
Cerebrospinal fluid concentration of foscarnet in patients with HHV-6 encephalitis after haematopoietic stem cell transplantation	44
Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study	43
Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization	43
Correction to: Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomon	40
Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate	40
Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching—authors’ response	39
Beyond the FIC index: the extended information from fractional inhibitory concentrations (FICs)	38
Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient	38
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals	38

Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus	37
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU—authors’ response	36
A drug candidate for Alzheimer’s and Huntington’s disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides	34
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections—authors’ resp	34
Comment on: A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections	34
Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?	34
Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, a	33
BSAC Vanguard Series: Tracking the global rise of antimicrobial resistance	33
Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveil	33
The case for ‘conservative pharmacotherapy’—authors’ response	33
Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases	32
Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings	32
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations	32
CATALYST: challenging antibiotic allergy status	31
Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects	31
Correction to: Advances in antibacterial treatment of adults with high-risk febrile neutropenia	31
Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species	30
Estimating the herd effects of antimicrobial prevention interventions on ventilator-associated pneumonia within ICU populations: a cluster randomized trial emulation using data from Cochrane reviews	30
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients–authors’ response	29
General practice antibiotic prescriptions attributable to respiratory syncytial virus by age and antibiotic class: an ecological analysis of the English population	29
Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trials	29
Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds	29
Diagnosis and management of refractory and rare moulds	28
Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment	28
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections	28
Syndromic testing for the diagnosis of infectious diseases: the right test if used for the right patient	27
Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance	26
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains	26
Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo	26
In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus	25
Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?	25
In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation	25
Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review	24
Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective	24
Extensively resistant Acinetobacter baumannii isolate RCH52 carries several resistance genes derived from an IncC plasmid	24
Off-label use of dalbavancin in children: a case series	24
The emergence of the ceftriaxone-resistantNeisseria gonorrhoeaeFC428 clone by transfer of resistance from an oralNeisseria subflavareservoir of resistance	24
Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB)	24
Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance	24
Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level	24
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species	24
A paediatric hospital care AMC report for Northern Ireland	24
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales	23
A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gen	23
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020–21	23
Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis	23
Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania	23
A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii	23
Remdesivir retreatment: another unproven intervention for COVID-19	22
Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation	22

Regulation of bla system in ST59-related oxacillin-susceptible mecA-positive Staphylococcus aureus	22
Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection	22
Dexamethasone is a dose-dependent perpetrator of drug–drug interactions: implications for use in people living with HIV	22
Influence of the COVID-19 pandemic on the defined daily dose of antimicrobials in patients requiring elective and emergency surgical procedures	22
Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients	22
Low CD4 counts predict excessive weight gains during first-line treatment for HIV	22
Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections	22
Fluoroquinolones and the risk for incidental seizures: a comparative retrospective study	22
Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern	21
Co-location of the oxazolidinone resistance poxtA2 and cfr(D) genes on a multiresistance plasmid from a porcine Streptococcus dysgalactiae subsp. equisimilis, Italy	21
WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing	21
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases	21
An XDR Proteus vulgaris isolate hosting a novel blaNDM-1- and armA-carrying plasmid	21
Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay	21
Evaluation of amoxicillin, metronidazole and gentamicin dosage regimens for use in antibiotic prophylaxis in colorectal surgery	21
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection	21
Evaluation of the RESIST ACINETO multiplex immunochromatographic assay for detection of OXA-23-like, OXA-40/58-like and NDM carbapenemase production in Acinetobacter baumannii	21
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis an	21
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)	21
Rapid meropenem/vaborbactam NP test for detecting susceptibility/resistance in Enterobacterales	20
Rapid selection of a cefiderocol-resistantEscherichia coliproducing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor	20
Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study	20
Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients	20
Healthcare-associated vanA-positive Enterococcus faecium clone ST612 emerging as pathogen of companion animals in Brazil	20
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study	20
The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021	20
Recognition and management of clinically significant drug–drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionna	20
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance	20
Metabolic pathways and antimicrobial peptide resistance in bacteria	19
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate	19
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence	19
Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus	19
Ceftazidime/avibactam serum concentration in patients on ECMO	19
Emergence of tet(X2) in Acinetobacter pittii confers clinical resistance to tigecycline	19
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a ne	19
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting	19
Towards optimization of ceftazidime dosing in obese ICU patients: the end of the ‘one-size-fits-all’ approach?	19
Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring	19
Measuring the impacts of the Using Antibiotics Wisely campaign on Canadian community utilization of oral antibiotics for respiratory tract infections: a time-series analysis from 2015 to 2019	19
Outcome selection in primary care antimicrobial stewardship research	19
The effect of novel aromatic heterocycle substituted aminamidine derivatives on Necator americanus	18
Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far	18
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study	18
Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model	18
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis	18
Temocillin for febrile urinary tract infections caused by ESBL-producing Enterobacteriaceae in children: a monocentric exposed/non-exposed study	18
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine	18
Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020	18
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run	18
Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-anal	18
Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China	18
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs)	18
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes	18
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam	17
A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum	17
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019	17
Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected man	17
Chloramphenicol versus ceftriaxone for the treatment of pneumonia and sepsis in elderly patients with advanced dementia and functional disability. A propensity-weighted retrospective cohort study	17
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations	17
The use of continuous electronic prescribing data to infer trends in antimicrobial consumption and estimate the impact of stewardship interventions in hospitalized children	17
Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA	17
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2	17
Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptib	17
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient	17
Diagnosis-linked antibiotic prescribing quality indicators: demonstrating feasibility using practice-based routine primary care data, reliability, validity and their potential in antimicrobial steward	17
Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium	17
Fostemsavir to overcome drug–drug interactions in heavily treatment-experienced people with HIV and cancer	17
Characterization of staphylococcal cassette chromosome mec in Staphylococcus haemolyticus ST3 and ST42 isolates from bovine mastitis milk: identification of novel variant in class C1	17
Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study—authors’ response	17
Post-report antibiotic initiation following community non-sterile-site microbiology results: an opportunity for labs to lead stewardship?	17
Differences in antibiotic use between COPD and non-COPD residents based on the health information system	17
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort	16
Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region	16
Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype	16
Nosocomial dissemination of blaIMP-4 among Klebsiella pneumoniae by horizontal gene transfer and clonal spread: the epidemic IncN plasmids and the emerging high-risk IMP-4-producing ST10	16
Effects of remdesivir on SARS-CoV-2 viral dynamics and mortality in viraemic patients hospitalized for COVID-19	16
Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions	16
Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from	16
Precision dosing of vancomycin: in defence of AUC-guided therapy in children	16
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV	16

Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation—authors’ response	16
Strategies to reduce antimicrobials in livestock and aquaculture, and their impact under field conditions: a structured scoping literature review	15
Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels	15
Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients	15
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco	15
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review	15
Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus	15
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir	15
Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain	15
Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis	15
Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model	15
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals	15
Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children’s hospitals in Japan	15
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria—authors’ response	15
Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time–kill experiments: agreement with in silico predictions	15
Specific mutations in the HIV-1 G-tract of the 3′-polypurine tract cause resistance to integrase strand transfer inhibitors	15
Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?	15
The primary pharmacology of ceftazidime/avibactam: resistancein vitro	15
Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance	15
Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance	15
Distribution and expression of the aac(6′)-Im (aacA16) aminoglycoside resistance gene	15
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study	15
Emergence of NDM-1, VIM-4 and CTX-M-15-co-harbouring Enterobacter xiangfangensis in a bloodstream infection	15
Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study	15
Host stress hormone norepinephrine reduces in vitro activity of aminoglycoside against carbapenemase-producing Enterobacterales	15
Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study	15
Saliva-based point-of-care assay to measure the concentration of pyrazinamide using a mobile UV spectrophotometer	14
Does calculation method matter for targeting vancomycin area under the curve?	14
Why we prescribe antibiotics for too long in the hospital setting: a systematic scoping review	14
Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus	14
Establishment of epidemiological cut-off values of etimicin: a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudom	14
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina	14
Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study	14
Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections	14
Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa	14
Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells	14
Point-of-care tests to manage acute respiratory tract infections in primary care: a systematic review and qualitative synthesis of healthcare professional and patient views	14
Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testin	14
Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans	14
Comment on: Deleterious effects of a combination therapy using fluoroquinolones and tetracyclines for the treatment of Japanese spotted fever: a retrospective cohort study based on a Japanese hospital	14
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence ofClostridioides difficileinfection: a propensity score analysis	14
Global emergence of Escherichia coli with PBP3 insertions	14
Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark	14
Screening for β-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs	14
Novel optrA-carrying integrative and conjugative element in a porcine Streptococcus suis, Italy	14
Novel macrolide-lincosamide-streptogramin B resistance gene erm(54) in MRSA ST398 from Germany	14
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy	14
Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepancies	14
Characterization of a carbapenem-resistant Escherichia coli from dairy cattle harbouring blaNDM-1 in an IncC plasmid	14
Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?	14
Oral ciprofloxacin activity against ceftriaxone-resistantEscherichia coliin anin vitrobladder infection model	14
Clinical exposure–response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection model	14
Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis	14
Estimating the impact of cefuroxime versus cefazolin and amoxicillin/clavulanate use on future collateral resistance: a retrospective comparison	14
The efficacy of antimicrobial solutions against multispecies bacterial biofilm with or without negative pressure wound therapy in an in vitro wound model	14
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV	14
Critical assessment of commercially available microtitre panels for antimicrobial susceptibility testing of veterinary pathogens	14
Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France	14
Neisseria gonorrhoeae treatment failure to the recommended antibiotic regimen—Québec, Canada, 2015–19	14
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection	14
Implication of genotypes for prognosis of Candida glabrata bloodstream infections	14
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model	13
Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records	13
In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration	13
Integrase inhibitors in children and adolescents: clinical use and resistance	13
Unmet needs and practical solutions in the management of invasive mould infections in Asia	13
Investigation on the reversal effect of closantel on colistin resistance in MCR-1 positive Escherichia coli based on dose–response relationship	13
Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysis	13
Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials—authors’ response	13
Comment on: Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study	13
Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation	13
Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan	13
Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study	13
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France	13
Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings	13
A genetic cluster of OXA-244 carbapenemase-producing Escherichia coli ST38 with putative uropathogenicity factors in the Netherlands	13
Novel approach using automated target enrichment enables culture-independent accurate whole-genome sequencing of Neisseria gonorrhoeae directly from clinical urogenital and extragenital specime	13
SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase	13
Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates	13
Clonal dissemination of MDR Pasteurella multocida ST79 in a small Swiss veal calf farm with high use of antibiotics	13
Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches	13
A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004–20 in Spain	13
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model	13
Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli	13
Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance	13
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance	13
Efficacy of nintedanib as a host-directed therapy candidate in the treatment of tuberculosis	13
Development of an optimized and practical pharmacokinetics/pharmacodynamics analysis method for aztreonam/nacubactam against carbapenemase-producingK. pneumoniae	13
Affinity of cefotiam for the alternative penicillin binding protein PBP3SAL used by Salmonella inside host eukaryotic cells	13
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain	12
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study	12
Comment on: The case for ‘conservative pharmacotherapy’	12
Characterization of a prophage and a defective integrative conjugative element carrying the optrA gene in linezolid-resistant Streptococcus dysgalactiae subsp. equisimilis isolate	12
Variation in approaches to antimicrobial use surveillance in high-income secondary care settings: a systematic review	12
Use of echinocandins combined with clindamycin in Pneumocystis pneumonia: a case series of 14 patients	12